Dr. Sheri Wen Hsu, MD

Dr. Hsu practices at Sheri Wen Hsu, M.D., Inc in La Quinta, California.

Dr. Hsu's NPI, 1831300722, was assigned on May 24, 2007. Dr. Hsu graduated from Lewis Katz School of Medicine in 2005. Dr. Hsu holds California license A97156.

Dr. Hsu's primary practice is Sheri Wen Hsu, M.D., Inc, at 47110 Washington St, La Quinta, CA 92253 in Riverside County. The practice phone is (760) 771-1111.

Dr. Hsu's primary practice is Sheri Wen Hsu, M.D., Inc in La Quinta, California. Dr. Hsu is also affiliated with Eisenhower Health. The medical group on file is Desert Rheumatology Clinic. Dmand AI also links Dr. Hsu to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hsu practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Hsu's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Hsu is board certified in internal medicine by the American Board of Internal Medicine. Dr. Hsu is licensed in California.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Hsu treats.

CMS data shows 111,548 Medicare services from Dr. Hsu across 17 procedure codes in 2024, for 838 Medicare patients. Medicare paid $785,316 for them. Every service was in an office.

CMS counts 838 Medicare patients who saw Dr. Hsu in 2024. The largest group is 65 to 74, with 354 patients. 75% of them have arthritis, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hsu's median patient age at 62, with 79% women.

In 2024, Dr. Hsu wrote 10,888 Medicare Part D claims for 1,295 patients. 84% of them were for generic drugs. CMS names the drug for 10,392 of them, across 105 drugs with 11 or more claims each, at $7,255,770 in total drug cost. In 2023, CMS named 10,710 claims across 98 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Hsu for performance year 2024, reported individually. Dr. Hsu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hsu as offering telehealth.

Dmand AI links 3 papers to Dr. Hsu, published from 2014 to 2015. 2015 was the busiest year, with 2. Dr. Hsu's most frequent co-authors are Keith K. Colburn, MD, Nasim S. Daoud, MD and Ioana Moldovan, MD.

CMS Open Payments shows 2,428 general payments to Dr. Hsu from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Amgen Inc. paid the most, $10,348.

Dmand AI lists 2 awards for Dr. Hsu, most recently CMS Stage 1 EHR in 2013.

Dr. Hsu graduated from Lewis Katz School of Medicine in 2005. Dr. Hsu is a member of ACR.

Dr. Hsu is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.